Australia
Co-founder of Brisbane-based gut analysis company Microba, Professor Gene Tyson, will head up a new field of microbiome-focused research at the Queensland University of Technology.
Kazia Therapeutics is company focused on developing anti-cancer drugs.
Biopharma and life sciences companies bolster their leadership teams and board with this week’s Movers & Shakers.
Global reach extended to major pharma market in Oceania
Parnell announces 2019 year-to-date revenue growth of 9% over the first 9 months of 2018, start of work on its new 2019 CMO contract, and updates to 2019 financial results.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Follows recent study results showing CelGro® facilitates high quality nerve repair and restores function to previously paralysed muscles
PERTH, AU, Dec 13, 2019 - - Holista CollTech announced that it has filed its 100%-owned global patent for platform technology that will deliver many fat-soluble medications by creating a water-soluble delivery system.
Peregrine Ventures, a leading Israeli med-tech venture capital fund, just closed its fourth fund, Peregrine 4, raising $115 million.
Promise Proteomics, the Grenoble-based experts in protein quantification in biological samples, announce that they are launching their first product on the diagnostics and personalised medicines market with their mAb-X-mise range of diagnostic kits for the therapeutic follow-up of biologics.
PRESS RELEASES